Any effect of CYP2C9 variants on warfarin clearance in Chinese patients?
You
Joyce H S
JH
Zuo
Zhong
Z
Lo
Cindy M Y
CM
Zhou
Limin
L
Yiu
Hillary H W
HH
Chau
Carrie T S
CT
Choi
Kai Chow
KC
Choi
David K M
DK
Wong
Raymond S M
RS
Cheng
Gregory
G
D000367:Age Factors; D000368:Aged; D000925:Anticoagulants / Q000737:chemistry / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D044466:Asian People / Q000235:genetics; D015331:Cohort Studies; D065729:Cytochrome P-450 CYP2C9; D005260:Female; D014644:Genetic Variation; D006723:Hong Kong; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate / Q000235:genetics; D008875:Middle Aged; D013237:Stereoisomerism; D014859:Warfarin / Q000737:chemistry / Q000493:pharmacokinetics*
D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases